Provided by Tiger Trade Technology Pte. Ltd.

CSTONE PHARMA-B

5.650
-0.250-4.24%
Volume:2.94M
Turnover:16.40M
Market Cap:9.02B
PE:-17.95
High:5.895
Open:5.895
Low:5.420
Close:5.900
52wk High:10.410
52wk Low:4.010
Shares:1.60B
HK Float Shares:1.60B
Volume Ratio:0.62
T/O Rate:0.18%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.315
ROE:-52.14%
ROA:-14.44%
PB:5.96
PE(LYR):-17.95
PS:18.12

Loading ...

Cstone Pharmaceuticals - Company to Initiate Global Phase Iii Mrcts for Cs2009 by End of 2026

THOMSON REUTERS
·
Jul 23

CStone Highlights Promising Phase I/II Data for Trispecific Antibody CS2009 Ahead of ESMO 2026

Bulletin Express
·
Jul 20

CStone Pharma's CS2009 Tri-Specific Antibody Data Accepted for ESMO 2026 Presentation

Stock News
·
Jul 20

CStone Pharma Reports Stable Share Capital in June; 4.60 Million Shares Repurchased Pending Cancellation

Bulletin Express
·
Jul 07

CStone Pharmaceuticals (SEHK:2616) Expands Sugemalimab Reach As Valuation Questions Linger

Simply Wall St.
·
Jul 05

CStone Pharma completes HKD 21.35 million share buybacks, 0.29% of share capital awaiting cancellation

Bulletin Express
·
Jun 29

Cstone Files HKEX Next-day Disclosure Return on Share Repurchase for Cancellation

Reuters
·
Jun 29

CStone Pharmaceuticals-B Shares Surge Over 6% in Early Trading Following Exclusive Commercialization Deal for Sugemalimab in Australia and New Zealand

Deep News
·
Jun 29

CStone Pharmaceuticals-B Executes Share Buyback on June 25

Stock News
·
Jun 26

Cstone Pharmaceuticals Files HKEX Next-day Disclosure Return on Share Repurchase for Cancellation

Reuters
·
Jun 26

CStone Pharma Taps Arrotex to Commercialize Sugemalimab in Australia, New Zealand

MT Newswires Live
·
Jun 26

Hong Kong Market Announcement Highlights: Six Companies Including Keytop Parking and WENGE AI List Today; Bosideng Annual Profit Attributable to Shareholders Rises 13.7% to Approximately RMB 39.94 Billion

Stock News
·
Jun 26

New Energy System Blueprint and Rural EV Initiative Unveiled as Key Stocks Report Earnings

Stock News
·
Jun 26

CStone Pharma repurchases 4.18 million shares, equal to 0.26 % of outstanding capital

Bulletin Express
·
Jun 25

Cstone Pharmaceuticals - to Receive Upfront Payment, Milestone Payments, and Profit Share from Arrotex

THOMSON REUTERS
·
Jun 25

Cstone Pharmaceuticals - Enters Exclusive Commercialization Agreement with Arrotex for Sugemalimab in Australia and New Zealand

THOMSON REUTERS
·
Jun 25

CStone Pharma buys back 0.50 million shares on 24 June; cumulative un-cancelled repurchases reach 3.84 million

Bulletin Express
·
Jun 24

CStone Pharmaceuticals-B Executes Share Buyback, Spending HK$2.4 Million

Stock News
·
Jun 24

Cstone Files HKEX Next-day Disclosure Return on Share Repurchase for Cancellation

Reuters
·
Jun 24

CStone Pharmaceuticals: All AGM Resolutions Secure Shareholder Approval; CEO Equity Incentive Plan Backed by 86.94% of Votes

Bulletin Express
·
Jun 24